Summary
C was given orally and parenterally to man and rats, and by direct injection into the caecum in rats. From the differences in urinary excretion after oral and parenteral administration intestinal absorption of tartrate was calculated as 18% of the dose in man and 81% in rats. Urinary tartrate was equivalent to 14% of the dose in man and 70% in rats, the differ ence between absorption and urinary excretion representing metabolism in body tissues.
2. Both man and the rat excreted part of the U C as respiratory carbon dioxide. This occurred to a small extent after parenteral injection, suggesting metabolism of tartrate by body tissues, but was greater after oral or intracaecal administration, indicating that the main site of tartrate metabolism is the intestine.
3. Several genera of intestinal bacteria were shown to liberate ["Clcarbon dioxide from labelled tartrate, and in a faecal incubation system Ltartrate, the natural isomer, was metabolized five times as rapidly as D-tartrate.
4. Oral sodium L-tartrate, 1-5 mmol day -1 kg -1 , was given to two subjects and was shown to alkalinize the urine like sodium salts of other organic acids which are metabolized in the body. The reduction in renal hydrogen ion excretion showed that an average of 84% of the dose was metabolized.
5. Only 5% of labelled tartrate given by mouth appeared in faeces, and pharmacological doses of unlabelled L-tartrate had little or no aperient effect.
Introduction
L-Tartaric acid (2,3-dihydroxysuccinic acid) is present in many fruits, and is widely used as an aperient, in baking powder, and as a constituent of effervescent drinks. Extensive use over many years suggests that it is not toxic, but Robertson & Lonnell (1968) reported a death in man, associa ted with renal tubular changes, after ingestion of approximately 30 g of tartaric acid, and Krop & Gold (1945) described renal tubular damage in a dog ingesting tartrate (1-0 g/kg) daily for 3 months.
Previous studies of tartrate metabolism in animals and man used non-radioisotopic tech niques with variable and sometimes conflicting results, though some of these differences may have been due to species variation (Underhill, Leonard, Gross & Jaleski, 1931a) . Most workers agree that in man after oral ingestion tartrate is not found in the stool and urinary recovery is incomplete (Underhill, Peterman, Jaleski & Leonard, 1931b; Finkle, 1933) , but whether it is absorbed or metabolized within the intestinal lumen by bacteria, or disappears by a combination of these two mechanisms, is not yet established. In most species, including man, parenteral tartrate appears largely unchanged in the urine (Finkle, 1933) , which suggests that any metabolism occurring after oral ingestion takes place within the intestinal lumen.
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The end result of complete oxidation of tartrate, as with other organic anions, must be the production of bicarbonate, which would have an alkalinizing effect on body fluids (Post, 1914; Pratt & Swartout, 1933) .
Any toxicity of tartrate is probably dependent on the amount of anion absorbed from the intestine, whereas the purgative effect is likely to depend on the osmotic activity of the fraction unabsorbed. The alkalinizing effect will be determined by the proportion metabolized, whether by intestinal bacteria or by body tissues after absorption. A clearer understanding of the fate of ingested tartrate is needed, therefore, from a medical and toxicological viewpoint.
The purpose of this study was first to determine the extent of absorption and metabolism of sodium [ l4 C]tartrate in the rat and man, and second to study quantitatively the effect of tartrate ingestion upon acid-base status in man.
Materials and methods

Isomeric forms oftartaric acid
Tartaric acid has two asymmetrically substi tuted carbon atoms, and so exists in three isomeric forms: L-tartaric acid, D-tartaric acid and mesotartaric acid. L-Tartaric acid is the naturally occurring form which concerns us here, and was used in human experiments which did not involve 14 C labelling. No commercial preparation of L-[ 14 Cltartaric acid is available, and our tracer experiments were therefore performed with the re labelled racemic DL mixture. As a general rule naturally occurring Lcompounds are more rapidly and completely meta bolized than their un-natural D-isomers. This was so in our own studies of tartrate metabolism in a faecal incubation system, and our isotope studies with DL-tartrate must therefore have over-estimated metabolism of D-tartrate and under-estimated metabolism of the L-isomer. However, in some experiments more than 50% of the tracer dose was metabolized, providing firm evidence that some of the D-form was metabolized, as was also shown by our faecal incubation studies.
Experimental
Metabolism of sodium DL-[
14 C]tartraie in rats. Three groups of rats weighing 200-250 g were given 20 μ€\ of sodium DL-[ 1,4-"Cltartrate with 18-8 mg/kg (0-081 mmol/kg) of L-tartrate as carrier, by three different routes: intraperitoneal, by gastric tube, and by injection directly into the caecum at open operation. Specific radioactivity of C0 2 in breath was measured at 30 min intervals for 6 h, and urinary excretion of labelled tartrate was measured over 24 h. Urine was first acidified to pH 2 to eliminate any 14 C present as bicarbonate, causing loss of less than 1% of total urinary radio activity, and thin-layer chromatography (see below) showed that the remaining radioactivity was in tartrate. Mean total recovery of the isotope was 72%; the remainder could have been excreted in the breath after 6 h, or in the faeces, which were not collected.
Metabolism of sodium DL-[ l4 C]tartrate in man. Five normal subjects aged 28-45 years took 5 //Ci of sodium DL- [l,4- 14 C]tartrate, with sodium Ltartrate as carrier at one of three different doses (2-5, 5-0 or 10-0 g), together with 12-5 g of Dxylose, in 80 ml of water. The specific radio activity of labelled C0 2 in breath was measured at hourly intervals, and urinary [
14 C]tartrate excretion in hourly collections for the first 7 h. Stools were weighed immediately they were passed, and analysed as described below. The excretion of I 14 C]tartrate in urine and stool and as respiratory CO 2 were expressed as percentages of the radio activity administered. Hourly excretion profiles were plotted for urinary [ 14 C]tartrate and res piratory 14 C0 2 and compared with the excretion profile of D-xylose in urine, a substance of similar molecular size to tartrate which is known to be passively absorbed from the small intestine and partly excreted unchanged in the urine.
One subject received 10 //Ci of DL-[1,4-14 C]-tartrate intravenously together with 125 mg (0-55 mmol) of sodium L-tartrate as carrier, and urine and breath were analysed for 8 h in the same way.
All experiments had the approval of the Univer sity College Hospital Ethical Committee.
Metabolism of sodium OL-[ u C\tartrate by in testinal bacteria. The technique used estimated the proportion of the carboxyl groups in tartrate which were converted by bacteria into C0 2 . Pure cultures of representative organisms from each of the major groups of intestinal bacteria were studied. Each organism was cultured for 48 h in Robertson's cooked meat broth, and 0· 1 ml was then trans ferred to 10 ml of tartrate broth at pH 7-2 (Difco brain-heart infusion broth with 1% yeast extract and L-tartrate, 43-5 mmol/1, labelled with 0-10//Ci of DL-[ 14 Cltartrate/ml) and incubated anaerobically for 48 h at 37°C. This period approximates to the colonic transit time of most normal subjects and was chosen to give anaerobic organisms ample time for growth and metabolism. After incubation 1 ml of perchloric acid solution (2·0 mol/1) was added and the broth was shaken with a few glass beads for 1 h at 37°C to release any U C0 2 . Samples were then analysed for residual [ 14 Cltartrate. Uninoculated broths containing label led tartrate were similarly treated, and showed 98-5-101 ·6% recovery of isotope.
Metabolism of unlabelled sodium D-and Ltartrate in a faecal incubation system. In the previous experiments representatives of each group of faecal bacteria were found to be capable of converting labelled DL-tartrate (the racemic mix ture) into C0 2 . Although on first principles it was likely that L-tartrate was metabolized more rapidly than the D-isomer, it was necessary to compare the metabolism by faecal bacteria of the two isomers by use of a chemical method, and the procedure of Underhill, Peterman & Krause (1931c) was fol lowed.
Experiments were performed on faeces from five healthy subjects aged 22-61 years. In each study a fresh stool from a single subject was mixed by kneading through a polythene bag in 1-5 times its weight of sodium chloride solution (15-4 mmol/1). Three 50 ml aliquots were taken and mixed (1) with 30 ml of sodium chloride solution (154 mmol/1), (2) with 30 ml of sodium L-tartrate (250 mmol/1), and (3) with 30 ml of sodium D-tartrate (250 mmol/1). Samples were then incubated anaerobically at 37°C for 24 h with the system described by Vince, Down, Murison, Twigg & Wrong (1976) . At zero time and at 3, 6, 7-5 and 24 h, 5 ml samples were removed for measurement of residual tartrate.
Changes in systemic acid-base state after oral sodium L-tartrate. Urinary hydrogen ion excretion and stool weights were measured daily in two normal subjects before, during and after ingestion of unlabelled sodium L-tartrate, 1-5 mmol/kg daily in three divided doses. In one subject changes in plasma total C0 2 and urinary tartrate were measured and in both all urine samples were analysed for protein and serial measurements of creatinine clearance were performed. Since the complete metabolism of 1 mmol of sodium tartrate would produce 2 mmol of bicarbonate, and a consequent reduction in urinary hydrogen ion excretion by 2 mmol, the fraction of ingested tartrate metabolized to bicarbonate could be calculated from the change in urinary hydrogen ion excretion.
Tartaric acid from The Radiochemical Centre (Amersham, Bucks, U.K.) was shown to be at least 98% radiochemically pure by thin-layer chromatography on cellulose acet ate, with ps°pan-l-ol/eucalyptol/formic acid (14-5:41·5:15, by vol.). The stable sodium L-and D-tartrate preparations used both had a purity of over 99%.
Urine samples were collected in plastic bottles containing a few crystals of thymol. In the radioisotopic experiments samples of urine were counted for I4 C content directly in water-soluble scintil lation fluid (PCS) with internal standard quench correction. Further samples were applied to a BioRad AG 2-X8 anion-exchange resin column (acetate phase), and the urinary organic acids eluted with formic acid (19-5 mol/1), evaporated to dryness under nitrogen, dissolved in isopropyl alcohol and chromatographed as described above. Duplicate plates were developed with Bromocresol Green to identify organic acids and ammonium metavanadate to stain tartaric acid. After identification the 14 C content of individual spots was measured by liquid scintillation counting. In non-isotopic experiments sodium tartrate was measured in urine by a micro-modification of the metavanadate method of Underhill, Peterman & Krause (1931c) .
Stools passed after ingestion of labelled sodium tartrate were homogenized and a sample centrifuged at 40 000 g. The supernatant was counted for 14 C content, and the radioactivity shown to be in tartrate by the method described for urine. In the faecal incubation experiments 5 ml samples of incubate were taken into 30 ml of boiling 2% trichloroacetic acid, cooled, made up to 50 ml and decolorized with activated charcoal as described by Underhill, Peterman & Krause (1931 c) . The pH was then adjusted to 7-0 with sodium hydroxide solution (1 -0 mol/1), 1 ml of sample was mixed with 1 ml of sodium metavanadate solution (164 mmol/1) and 1 ml of acetic acid and left for 55 min at room temperature and absorption then read at 550 nm.
Excretion of labelled C0 2 was measured in man by collecting 2 mmol samples of expired C0 2 in plastic scintillation pots containing 2 ml of Hyamine hydroxide (1-0 mol/1) and 2 ml of absolute ethanol. Thymolphthalein was used as indicator and the I4 C content measured by liquid scintillation counting. The total I4 C output in breath was calculated by multiplying the mean specific radioactivity of expired C 0 2 over the measured interval by the amount of endogenous C 0 2 produced in the same time, obtained from tables relating C 0 2 output at rest to body size (Winchell, Stahelin, Kusubov, Slanger, Fish, PoUycove & Lawrence, 1970) . To measure C 0 2 excretion by rats, each animal was housed in a glass metabolic chamber through which air was pumped into a series of glass columns filled with small glass rings and contain ing Hyamine hydroxide, ethanol and thymolphthalein. Columns were arranged in series so that samples (2-5 mmol) of C 0 2 were collected at 30 min intervals and the specific radioactivity of C 0 2 was measured as described above. En dogenous C 0 2 production in the rat was measured directly in this system. Urinary D-xylose was estimated by the method of Roe & Roce (1948) and urinary hydrogen ion excretion during the acid-base studies was measured as ammonium plus titratable acid minus bicarbonate, as described by Wrong & Davies (1959) .
Results
Metabolism of sodium DL-1 u C]tartrate in rats
After intraperitoneal injection, 63· 1 ± SEM 5-2% was excreted in urine unchanged in 24 h and 9-4 ± 0-5% was excreted in 6 h as C0 2 , indicating significant tissue metabolism of tartrate. After oral administration 51-0 + 4-5% was excreted un changed in the urine, but a greater proportion, 21-8 ± 1-4%, appeared in expired C 0 2 than after intraperitoneal injection, suggesting that some of the tartrate had been metabolized within the intestine to bicarbonate. That this probably occur red as a result of bacterial metabolism in the caecum was suggested by the results of intracaecal injection, which showed that most of the isotope, 66-6 ± 4-6%, was excreted as C 0 2 in breath, and only a very small amount, 1-4 + 0-3%, was absorbed from this site and appeared in the urine.
Metabolism of sodium DL-[ l4 C]tartrate in man
Oral tartrate. From the raw data the percentage of administered I4 C recovered over 7 h in breath and urine appeared to be independent of the dose given (three dosages) and results from all five experiments have therefore been pooled. In con trast to the findings in the rat, the major route of excretion was as labelled CO, in breath (46-2 ± 8-1%) and only 12-0 ± 1-2% of the dose was excreted unchanged in the urine. Four of the five subjects produced faeces in the 7 h after administration, and in some cases several fluid stools were passed, but mean faecal recovery of the label was equivalent to only 4-9 ± 1-7% of the dose, and later stools contained negligible amounts of the label.
Intravenous tartrate. After intravenous sodium tartrate in one subject, 63-8% of the dose was excreted unchanged in the urine over 22 h and 18-0% was excreted in breath as 14 C0 2 over 8 h. (Fig. 1) , suggesting rapid metabolism by tissue enzymes. Peak excretion after oral adminis tration was at 4 h, consistent with an increase in 1 4 C0 2 production at the time of exposure of the tartrate to colonic bacteria. 
Comparison between urinary excretion profiles for D-xylose and OL-[
u C]tartrate. After intravenous administration tartrate was rapidly excreted in the urine (Fig. 2) , indicating that the difference between the excretion profile after intravenous and oral administration must reflect the time required for intestinal absorption. After oral ingestion the peak excretion of [ 14 C]tartrate in urine was 1 h later than after intravenous injection and coincided with peak urinary D-xylose ex cretion.
Metabolism of labelled DL-tartrate by intestinal bacteria
All groups of intestinal organisms metabolized tartrate when grown for the first time in broth containing tartrate (Table 1) . On several occasions more than 50% of the radioisotopic label was converted into C0 2 , showing that both L-and Dforms of tartrate were metabolized. When tested a second time several aerobic organisms meta bolized more tartrate in 48 h than they had metabolized on primary exposure.
Metabolism of unlabelled D-and h-tartrate in a faecal incubation system
The rate of disappearance of tartrate varied widely with different samples of faeces, but in every case L-tartrate disappeared more rapidly than r> tartrate ( Table 2) . Because of insensitivity of the method it was not possible to measure accurately tartrate concentrations below 25% of the initial concentration, and so the time of complete disappearance of tartrate could not be determined. When tartrate concentrations were plotted logarithmically against time, 50% loss occurred at approximately 4 h with L-tartrate and 20 h with Dtartrate. excretion in subject A. During the 3 control days mean urine pH was 5-8. During the 2 days of tartrate administration urine pH rose to 7· 69 with a marked bicarbonate diuresis, urinary hydrogen ion excretion becoming negative on the second and third days. The deficit in hydrogen ion excretion from control values during the two experimental and subsequent 3 recovery days was 390 mmol, equivalent to 76·6% of the ingested dose of tartrate and indicating metabolism of approximately this proportion of the dose to bicarbonate. There was no proteinuria, and creatinine clearance was 115 ml/min before and 120 ml/min after ingestion of tartrate. Sodium tartrate had only a slight purgative effect (see faecal weight), which disappeared by the second day of administration. Fig. 4 shows the results from subject B, who took a constant diet in order to prevent fluctua tions in hydrogen ion production caused by variations in diet. Urine pH on the second to fourth control days was 6· 2-6-6, and urinary hydrogen ion excretion averaged 63 mmol/day. During tartrate administration and over the next 3 days the reduction in hydrogen ion excretion totalled 771 mmol, equivalent to 92-3% of the ingested dose. The total C0 2 content of venous plasma was 31-4 mmol/1 on the fourth control day, 34-0 on the fourth tartrate day, and 30-3 mmol/1 on the fourth day of the recovery period, showing that the alka- line urine caused by tartrate was not a consequence of renal damage impairing the mechanism of urinary acidification, but a normal renal response to the mild systemic alkalosis caused by the conversion of ingested sodium tartrate into bicar bonate. In keeping with the greater metabolism of tartrate in this study, the purgative effect was negligible, but urine output rose to 3500 ml/day, an effect attributable to the osmotic diuresis caused by excretion of the sodium bicarbonate load. There was no proteinuria, and creatinine clearance was 108 ml/min before and 104 ml/min after tartrate administration. Urinary tartrate excretion was 9-8, 9-4, 8-9 and 10-3 mmol on the 4 tartrate days respectively; total renal excretion was thus 38-4 mmol or 7-4% of the total administered dose.
Changes in systemic acid-base state in man after oral unlabelled sodium ^tartrate
Fate of carbon skeleton of tartrate anion
In the radioactive studies only atoms C-l and C-4 of the tartrate molecule were labelled with ,4 C; it was possible therefore that atoms C-2 and C-3 if not completely metabolized to C0 2 could have resulted in the production of an unlabelled, nonmetabolizable C 2 fragment such as oxalate. However, in the acid-base experiments conversion of tartrate into oxalate or other unmetabolized anion would have caused a proportional reduction in the change in urinary hydrogen ion excretion. In subject B 92-3% of ingested tartrate was metabolized to bicarbonate on the basis of the change in urinary hydrogen ion excretion and 7-4% was accounted for as unchanged tartrate in urine. Clearly, therefore, no significant formation of oxalate or other unmetabolized anion could have occurred. Urinary oxalate excretion was measured in this subject and was 0-24 ± SEM 0·04 and 0-22 + 0-05 mmol/day on the control and tartrate days respectively, confirming no conversion of ingested tartrate into oxalate.
Discussion
Intestinal absorption oftartrate
Up to 60% of labelled tartrate was absorbed in rats, in agreement with previous estimates (Un derbill et al., 1931a) . In man only 12% of oral tartrate appeared in the urine; this was unrelated to dose and similar in time-course to D-xylose, suggesting that absorption is passive. The marked difference in urinary excretion after an oral dose (12%) and an intravenous dose (66%) suggests that only a small proportion of the oral dose was absorbed in man.
Fate oftartrate after absorption
In rats up to 10% of labelled parenteral tartrate was expired as C0 2 within 6 h, whereas 63% was excreted in the urine over 24 h, which indicates significant metabolism by tissues. Underhill et al. (1931a) found that after parenteral injection of tartrate recovery ranged from 70% in rabbits, dogs and rats to almost 100% in guinea pigs, so that tissue metabolism could not be excluded in any of these species, though clearly it played a minor role in disposal oftartrate.
In man Finkle (1933) found that 91% of an intramuscular dose of unlabelled tartrate was recovered in urine, and concluded that the human body cannot metabolize tartrate. With intravenous ['"Cjtartrate we found that 66% was excreted in the urine in 22 h, but that 18% was excreted as C0 2 over 8 h, indicating slow tissue metabolism.
Fate ofunabsorbed tartrate
In rats after intracaecal injection of ['"Cjtartrate 67% was expired as C0 2 within 6 h, whereas less than 2% was recovered in the urine. This suggests only very limited absorption of caecal tartrate, but that active bacterial metabolism to bicarbonate or some precursor of bicarbonate occurred with rapid equlibration with the bicarbonate and C0 2 in blood to allow for the rapid appearance of the carbon label as 14 C0 2 .
In man 46% of oral [ 14 C]tartrate was metabolized to C0 2 within 7 h and only 5% appeared in stool, even when purgative doses were taken, suggesting that very little unabsorbed tartrate escapes metabolism by intestinal bacteria. The change in urinary hydrogen ion excretion after ingestion of non-radioisotopic sodium L-tartrate in subject B suggests that up to 92-3% of ingested tartrate was metabolized to bicarbonate, and since our tracer experiments showed poor absorption of oral tartrate most of this metabolism must have been by bacteria.
Bacterial metabolism oftartrate
We confirm that a wide variety of human intestinal bacteria metabolize tartrate (Maasen, 1895) . Some organisms (e.g. micrococci, strep tococci and Proteus mirabilis) metabolized more tartrate on repeated growth in tartrate broth, suggesting an adaptive process, which might explain the rapid decrease in purgation when tartrate was ingested for several days (Fig. 3 and Fig. 4) .
Our faecal incubates metabolized both L-and Dtartrate, but L-tartrate, which exists naturally in foods, was destroyed faster, suggesting that in testinal bacteria have adapted their metabolism to utilize it as a substrate. Many strains of coliform bacteria destroy the L-isomer more rapidly than Dtartrate (Vaughn, Marsh, Stadtman & Cantino, 1946) .
The colon is likely to be the main site oftartrate metabolism, as it has the most abundant bacterial flora. Despite our finding that intestinal bacteria formed bicarbonate from tartrate when grown in vitro in pure culture, it is possible that bicarbonate is not formed directly in the colon, where the low oxygen tension (Bornside, Cherry & Bert, 1973) and negative Eh (Wostmann & Bruckner-Kardoss, 1966; Vince et al., 1976) favour reductive rather than oxidative reactions. Splitting of the fourcarbon-atom tartrate molecule to glycollate, glyoxylate or oxalate also appears unlikely as these substances would be expected to increase urinary oxalate excretion, which was not found. Intestinal bacteria may split the tartrate molecule to two molecules of acetate, which is produced in large amounts by colonic bacteria (Rubinstein, Howard & Wrong, 1969) . Acetate has been shown to be a product of tartrate metabolism by lactobacilli (Radler & Yanissis, 1972) 1964; Bond & Levitt, 1976) ; its complete metabol ism after absorption would produce the observed effects on acid-base metabolism.
Effect of tartrate on acid-base state
Complete metabolism of sodium tartrate, as with sodium salts of other organic anions, would produce an equivalent amount of sodium bicarbon ate and hence would in turn produce an equivalent reduction in urinary hydrogen ion excretion (Relman, Lennon & Lemann, 1961) , irrespective of whether tartrate was metabolized in the tissues (Pratt & Swartout, 1933) or in the bowel, provided that the products of intestinal metabolism were absorbed. Incomplete oxidation of tartrate would result in proportionally reduced changes in urinary hydrogen ion excretion. In our two human studies with pharmacological doses of sodium L-tartrate, the reduction in urinary hydrogen ion excretion was equivalent to 76-6% and 92·3% of the dose, indicating that most of the ingested tartrate was metabolized, and our evidence that tartrate was poorly absorbed in man leads us to conclude that this metabolism was mainly intestinal.
Fate of oral tartrate in man
The various routes taken by ingested tartrate are shown in Fig. 5 , the percentages taking different routes being derived from the labelled DL-tartrate experiments. They are subject to the criticisms that only one experiment was performed with intra venous tartrate and also the percentage of Ltartrate metabolized may have been under estimated, as both intestinal bacteria and body tissues may metabolize the natural racemic mixture more slowly than the L-isomer. There was never theless excellent agreement with the two studies using pharmacological doses of L-tartrate, where a mean of 84% of ingested tartrate was metabolized, whereas the figure calculated from the radioisotopic studies was 81%. Fig. 5 enables calcula tion of the relative alkalinizing and aperient effects of L-tartrate, and it is clear that the former is large, a fact of little therapeutic advantage as there are many other organic anions (e.g. lactate, citrate, acetate) which are 100% alkalinizing to body fluids. The aperient effect of tartrate is small, in keeping with our own experience of doses which have been recommended for their aperient effect (Fig. 3 and Fig. 4) .
Toxicity of L-tartrate
In our two human studies using large pharmaco logical doses of L-tartrate there was no evidence of renal toxicity as creatinine clearance was normal and there was no proteinuria. In man the fact that so little tartrate is absorbed may help to explain its use over many years without evidence of harmful effects.
